BARCLAYS PLC - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 45 filers reported holding REDHILL BIOPHARMA LTD in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q4 2022$7
-100.0%
51,0000.0%0.00%
Q3 2022$26,000
-40.9%
51,0000.0%0.00%
Q2 2022$44,000
-77.2%
51,000
-33.3%
0.00%
Q1 2022$193,000
-51.0%
76,500
-50.0%
0.00%
Q4 2021$394,000153,000
+1912400.0%
0.00%
Q3 2021$0
-100.0%
8
-90.7%
0.00%
Q2 2021$1,0000.0%86
-31.2%
0.00%
Q1 2021$1,0000.0%125
+25.0%
0.00%
Q4 2020$1,000
-98.0%
100
-99.1%
0.00%
Q1 2020$51,00011,2000.00%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q2 2020
NameSharesValueWeighting ↓
Broadfin Capital, LLC 717,203$9,962,0000.89%
BANK HAPOALIM BM 147,504$2,049,0000.48%
MENORA MIVTACHIM HOLDINGS LTD. 246,000$3,417,0000.19%
Family Management Corp 16,500$229,0000.13%
Orbimed Advisors 564,900$7,846,0000.09%
SABBY MANAGEMENT, LLC 63,800$888,0000.03%
INGALLS & SNYDER LLC 41,550$577,0000.03%
Candriam S.C.A. 71,267$992,0000.02%
MONETARY MANAGEMENT GROUP INC 3,000$42,0000.02%
D.A. DAVIDSON & CO. 26,500$368,0000.01%
View complete list of REDHILL BIOPHARMA LTD shareholders